BC Week In Review | Jan 4, 2019
Financial News

Cellid proposes Korean IPO

Cell-based vaccine company Cellid Co. Ltd. (Seoul, South Korea) proposed on Dec. 13 to sell 1.2 million shares at W22,100-W27,000 in a Korean IPO, according to the Korean Stock Exchange's website. At the W24,550 mid-point,...
Items per page:
1 - 1 of 1